Cargando…

Advances in severe community-acquired pneumonia

Detalles Bibliográficos
Autores principales:	Wang, Jian, Song, Yuan-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708690/ https://www.ncbi.nlm.nih.gov/pubmed/31335475 http://dx.doi.org/10.1097/CM9.0000000000000366

Ejemplares similares

Adjunctive immunomodulation in severe community-acquired pneumonia
por: Bradley, James, et al.
Publicado: (2023)

Severe community-acquired pneumonia: in search of the guiding star
por: Póvoa, Pedro, et al.
Publicado: (2023)

Corticosteroids for severe community-acquired pneumonia: a story without an ending
por: Rochwerg, Bram
Publicado: (2022)

Advances in community-acquired pneumonia
por: Jones, Barbara, et al.
Publicado: (2020)

Severe Community-Acquired Pneumonia
por: Khatib, Khalid, et al.
Publicado: (2019)

Severe community-acquired pneumonia
por: Morgan, AJ, et al.
Publicado: (2016)

Severe Community-Acquired Pneumonia
por: Sligl, Wendy I., et al.
Publicado: (2013)

Severe community-acquired pneumonia
por: Niederman, Michael S., et al.
Publicado: (2022)

Community-acquired pneumonia: challenges of the situation in Brazil
por: Gomes, Mauro
Publicado: (2018)

Changes in the epidemiology and burden of community-acquired pneumonia in Korea
por: Yoon, Hyoung Kyu
Publicado: (2014)

Corticosteroids for all adult patients with community-acquired pneumonia?
por: Spoorenberg, Simone M. C., et al.
Publicado: (2015)

Ceftaroline in severe community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Steroids in severe community-acquired pneumonia: dangerous, worthless, or miracle cure? The roller coaster of clinical trials
por: Bouras, Marwan, et al.
Publicado: (2023)

Community-acquired pneumonia: The need to broaden our diagnostic armamentarium
por: Perumal, R, et al.
Publicado: (2020)

Advancements in the Management of Severe Community-Acquired Pneumonia: A Comprehensive Narrative Review
por: Davis, Don, et al.
Publicado: (2023)

Major advances in managing community-acquired pneumonia
por: Asrar Khan, Waseem, et al.
Publicado: (2013)

PES Pathogens in Severe Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Middle molecules in severe community-acquired pneumonia
por: Dumitras, T, et al.
Publicado: (2015)

Factors influencing severity of community-acquired pneumonia
por: Mahendra, M, et al.
Publicado: (2018)

Noninvasive ventilation routine therapy for community-acquired pneumonia? Not so fast!
por: Hill, N. S.
Publicado: (2001)

Community-acquired pneumonia in Korean children: time to read between the lines
por: Suh, Dong In
Publicado: (2022)

Pneumonia severity index in viral community acquired pneumonia in adults
por: Kim, Mi-Ae, et al.
Publicado: (2019)

Plasma kallistatin levels in patients with severe community-acquired pneumonia
por: Lin, Wei-Chieh, et al.
Publicado: (2013)

The debated problem of community-acquired pneumonia diagnosis: many guidelines, any guideline?
por: Infantino, Antonio, et al.
Publicado: (2013)

Advances in the prevention, management, and treatment of community-acquired pneumonia
por: Pletz, Mathias W, et al.
Publicado: (2010)

Advances in the prevention, management, and treatment of community-acquired pneumonia
por: Pletz, Mathias W., et al.
Publicado: (2016)

Recent Advances in Community-Acquired Pneumonia: Inpatient and Outpatient
por: Niederman, Michael S.
Publicado: (2007)

Prognostic assessment in community-acquired pneumonia by pneumonia severity scores and biomarkers
por: Dusemund, F, et al.
Publicado: (2010)

Mycoplasma pneumoniae and Adenovirus Coinfection Cause Pediatric Severe Community-Acquired Pneumonia
por: Li, Fei, et al.
Publicado: (2022)

ICU admission and severity assessment in community-acquired pneumonia
por: Chalmers, James D
Publicado: (2009)

Severe community-acquired pneumonia in the intensive care unit
por: Costa, C, et al.
Publicado: (2005)

Outcome of severe community-acquired pneumonia: the impact of comorbidities
por: Pereira, JM, et al.
Publicado: (2013)

Serum levels of immunoglobulins and severity of community-acquired pneumonia
por: de la Torre, Mari C, et al.
Publicado: (2016)

Corticosteroids as Adjunctive Therapy in Severe Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2016)

Current Concepts of Severe Pneumococcal Community-acquired Pneumonia
por: Luján, M., et al.
Publicado: (2007)

Current Concepts of Severe Pneumococcal Community-acquired Pneumonia
por: Luján, M., et al.
Publicado: (2007)

Clinical presentations and outcome of severe community-acquired pneumonia
por: Elshamly, Mousa, et al.
Publicado: (2016)

NETosis is critical in patients with severe community-acquired pneumonia
por: Zhang, Yiming, et al.
Publicado: (2022)

Biomarkers in community-acquired pneumonia: can we do better by using them correctly?
por: Ranzani, Otavio Tavares, et al.
Publicado: (2019)

Too Much or Too Little Empiric Treatment for Pseudomonas aeruginosa in Community-acquired Pneumonia?
por: Torres, Antoni, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_msb95639hmmhu4jaj6raseh6aj